Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Hideki Tsujimura"'
Autor:
Atsushi Kasamatsu, Yasushi Kimura, Hideki Tsujimura, Harusachi Kanazawa, Nao Koide, Isao Miyamoto, Yosuke Endo-Sakamoto, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa
Publikováno v:
Case Reports in Dentistry, Vol 2015 (2015)
Multiple myeloma is a malignant neoplasm of plasma cells characterized by proliferation of a single clone of abnormal immunoglobulin-secreting plasma cells. Since the amount of hemopoietic bone marrow is decreased in the maxilla, oral manifestations
Externí odkaz:
https://doaj.org/article/fff91beab29f494eb53ebcae8f6e9edb
Publikováno v:
BioTechniques, Vol 33, Iss 4S, Pp S66-S75 (2002)
Dendritic cells, macrophages, and granulocytes are derived from hematopoietic stem cells and provide a first line of defense against infectious pathogens. Toll-like receptors (TLRs) expressed on these cells recognize molecular structures present in t
Externí odkaz:
https://doaj.org/article/18a3f8387b374bf8a63d1b529b234a1c
Autor:
Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, Naoki Takahashi, Masahiro Yoshida, Hiroaki Morimoto, Yasuhiro Suzuki, Kazuyuki Shimada, Masanori Makita, Shuichi Ota, Hiroshi Gomyo, Hiroyuki Takahashi, Ritsuro Suzuki, Hiroo Katsuya, Hiro Tatetsu, Shuji Momose, Takahisa Yamashita, Kumiko Ohsawa, Naoko Asano, Dai Maruyama, Motoko Yamaguchi, Hirokazu Nagai
Publikováno v:
Blood. 140:11890-11892
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94354566aab87dbe87fdbf5ba4fb0348
https://doi.org/10.1182/blood-2022-164977
https://doi.org/10.1182/blood-2022-164977
Autor:
Masaki Ri, Shimon Nakashima, Miki Nakajima, Shinsuke Iida, Dai Maruyama, Satoshi Osaga, Kensei Tobinai, Noriko Fukuhara, Kana Miyazaki, Norifumi Tsukamoto, Hideki Tsujimura, Makoto Yoshimitsu, Kenichi Miyamoto, Kunihiro Tsukasaki, Hirokazu Nagai
Publikováno v:
Blood. 140:12647-12649
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9c522f05a6fbd9206a2df60cfcb17e5
https://doi.org/10.1182/blood-2022-156875
https://doi.org/10.1182/blood-2022-156875
Autor:
Takuto Nakashima, Dai Maruyama, Ryo Kamei, Kana Miyazaki, Kensei Tobinai, Hideki Tsujimura, Makoto Yoshimitsu, Noriko Fukuhara, Satoshi Osaga, Shinsuke Iida, Kunihiro Tsukasaki, Aya Sakabe, Hirokazu Nagai, Norifumi Tsukamoto, Masaki Ri, Ken-ichi Miyamoto, Masahiro Tohkin
Publikováno v:
Cancer Science
Bortezomib (Btz) shows robust efficacy in patients with multiple myeloma (MM); however, some patients experience suboptimal responses and show specific toxicities. Therefore, we attempted to identify specific HLA alleles associated with Btz‐related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c6efaec8a8865a0ab73d71de3d4842
https://doi.org/10.1111/cas.15158
https://doi.org/10.1111/cas.15158
Autor:
Dai Maruyama, Shinsuke Iida, Ryunosuke Machida, Shigeru Kusumoto, Noriko Fukuhara, Nobuhiko Yamauchi, Kana Miyazaki, Makoto Yoshimitsu, Junya Kuroda, Norifumi Tsukamoto, Hideki Tsujimura, Kensuke Usuki, Takahiro Yamauchi, Takahiko Utsumi, Ishikazu Mizuno, Yasushi Takamatsu, Yasuyuki Nagata, Shuichi Ota, Eiichi Ohtsuka, Ichiro Hanamura, Yasuhiro Suzuki, Shinichiro Yoshida, Satoshi Yamasaki, Youko Suehiro, Yutaro Kamiyama, Suguru Fukuhara, Kunihiro Tsukasaki, Hirokazu Nagai
Publikováno v:
Cancer science. 113(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f6d12476e38c9a5c5200997304be152
https://pubmed.ncbi.nlm.nih.gov/35909244
https://pubmed.ncbi.nlm.nih.gov/35909244
Autor:
Yoko Inaguma, Eiichi Ohtsuka, Yukiyoshi Moriuchi, Kazuho Miyashita, Masashi Mizokami, Nobuhiko Yamauchi, Tadahiko Igarashi, Koji Izutsu, Hiroshi Gomyo, Nobuko Kubota, Ryuzo Ueda, Mio Kurata, Yoshiko Inoue, Yoshiko Atsuta, Rika Sakai, Norifumi Tsukamoto, Yoko Ushijima, Kisato Nosaka, Dai Maruyama, Sachiko Suzuki, Toshiki Uchida, Shinichiro Yoshida, Ilseung Choi, Shigeru Kusumoto, Go Yamamoto, Yasuhito Tanaka, Kensuke Kojima, Satoshi Ichikawa, Hideki Tsujimura
Publikováno v:
Cancer Science
We conducted a nationwide retrospective analysis of 116 hepatitis B virus (HBV) surface antigen (HBsAg)‐positive patients with diffuse large B‐cell lymphoma (DLBCL) and 278 HBsAg‐negative patients with DLBCL, as a control cohort, who received r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0370dd68fe776aae56a8d763104043af
https://doi.org/10.1111/cas.14846
https://doi.org/10.1111/cas.14846
Autor:
Isao Yoshida, Katsuhiro Miura, Akiyo Yoshida, Ilseung Choi, Tadashi Yoshino, Jun Takizawa, Hideo Yagi, Yoshihiro Hatta, Shinobu Tamura, Masaki Iino, Koichi Kitazume, Kazuhiko Yamamoto, Yasufumi Masaki, Shigeo Nakamura, Taro Masunari, Ritsuro Suzuki, Masatoshi Kanno, Yoshinobu Maeda, Yasutaka Kakinoki, Hideki Tsujimura, Takashi Yoshida
Publikováno v:
Hematological Oncology. 39:51-59
Bendamustine and rituximab (BR) are widely used in patients with follicular lymphoma (FL) previously treated with conventional immunochemotherapy, but the role of consolidation radioimmunotherapy in these patients is unknown. This study evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48fcb0ea06b56a5915415508f5771d57
https://doi.org/10.1002/hon.2809
https://doi.org/10.1002/hon.2809
Autor:
Ryo Tominaga, Koichiro Minauchi, Yasuo Morishima, Yoshitoyo Kagami, Kazuhito Yamamoto, Michihide Tokuhira, Satoko Morishima, Shigeru Kusumoto, Shigeo Nakamura, Taro Shibata, Kisato Nosaka, Hirokazu Nagai, Shinichiro Yoshida, Kensei Tobinai, Junya Kuroda, Youko Suehiro, Nobuhiko Yamauchi, Michinori Ogura, Yasushi Kubota, Kunihiro Tsukasaki, Kazuyuki Shimada, Dai Maruyama, Noriko Fukuhara, Yoshihiro Yakushijin, Akira Hangaishi, Hideki Tsujimura, Hirofumi Kobayashi, Yasushi Takamatsu, Yoshiko Inoue, Tomomitsu Hotta, Toshiki Uchida, Yoshitaka Imaizumi, Sachiko Suzuki
Publikováno v:
Cancer Science
The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly diagnosed high‐risk diffuse large B‐cell lymphoma (DLBCL) may be influenced by induction chemotherapy. To select be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7450511a440b266d76864502962b115
https://doi.org/10.1111/cas.14604
https://doi.org/10.1111/cas.14604
Autor:
Hirokazu Nagai, Gakuto Ogawa, Shinsuke Iida, Ishikazu Mizuno, Eiichi Ohtsuka, Takahiro Yamauchi, Dai Maruyama, Noriko Fukuhara, Koichiro Minauchi, Junya Kuroda, Shinichiro Yoshida, Youko Suehiro, Hideki Tsujimura, Yasuyuki Nagata, Kunihiro Tsukasaki, Satoshi Yamasaki, Sachiko Seo, Kana Miyazaki, Makoto Yoshimitsu, Akira Hangaishi, Norifumi Tsukamoto, Takahiko Utsumi, Yutaro Kamiyama, Ichiro Hanamura, Yasushi Takamatsu
Publikováno v:
British Journal of Haematology
Summary We conducted a randomised phase II study to determine the optimal dose and schedule of melphalan, prednisone, and bortezomib (MPB) (jRCTs031180097). Transplant‐ineligible untreated multiple myeloma patients were randomised to Arm A (twice w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0ea49c985c8e5a798051ee420152dc
https://doi.org/10.1111/bjh.16878
https://doi.org/10.1111/bjh.16878